ArticleCancer research and treatment2022

The Impact of EGFR Tyrosine Kinase Inhibitor on the Natural Course of Concurrent Subsolid Nodules in Patients with Non-Small Cell Lung Cancer.

Noeul Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.